Vijaya Diagnostic Centre Limited has announced its financial results for the first quarter of FY27, reporting a robust 22.8% year-on-year revenue growth. Total revenue reached ₹2,309.8 million, driven by a volume increase of approximately 16.5%. Profit After Tax (PAT) saw a significant surge of 37.6% to ₹531.0 million, with PAT margin improving by 247 basis points. The company also highlighted expansion initiatives, including new diagnostic centres and advanced imaging technologies.
Vijaya Diagnostic Centre Reports Strong Q1 FY27 Performance
Vijaya Diagnostic Centre Limited announced its financial results for the quarter ended June 30, 2026, showcasing a strong year-on-year performance. The company’s consolidated revenue from operations for Q1 FY27 stood at ₹2,309.8 million, marking a significant increase of 22.8% compared to ₹1,880.5 million in the corresponding quarter of the previous fiscal year (Q1 FY26). This growth was substantially supported by a volume increase of approximately 16.5% in total tests.
Key Financial Highlights for Q1 FY27
The company’s Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew by 34.0% to ₹985.4 million in Q1 FY27, up from ₹735.3 million in Q1 FY26. The EBITDA margin improved to 42.7% from 39.1% in the prior year. Profit After Tax (PAT) witnessed a substantial jump of 37.6%, reaching ₹531.0 million in Q1 FY27, compared to ₹385.9 million in Q1 FY26. Consequently, the PAT margin expanded by 247 basis points to 23.0%.
Operational and Expansion Initiatives
In terms of operational performance, total tests conducted increased by 16.5% to 4.59 million, and total footfall rose by 12.7% to 1.24 million. The average realization per test saw a 5.5% increase, reaching ₹503. The company also reported the commissioning of new facilities, including a hub centre in Gachibowli, Hyderabad with a 160-slice cardiac CT, and its flagship hub centre in Bengaluru featuring advanced imaging technologies like a digital PET-CT and a wide bore 75cm 3T Omega MRI.
Source: BSE
